Stocks and Investing Stocks and Investing
Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022
Sun, March 6, 2022
Fri, March 4, 2022

Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $54 on, Mar 4th, 2022


Published on 2024-10-27 19:58:04 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Decreased Target from $55 to $54 on, Mar 4th, 2022.

Robert has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Robert's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Robert


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $29 on, Tuesday, February 1st, 2022
  • Andrew Galler of "Wolfe Research" Initiated at Buy and Held Target at $44 on, Tuesday, November 9th, 2021